GALD — Galderma AG Share News
0.000.00%
Last trade - 00:00- CH₣40.44bn
- CH₣42.01bn
- $5.24bn
Switzerland's Galderma falls after UBS cuts rating on limited upside
Brief: Galderma Group AG - New Data Demonstrate Nemluvio®'S (Nemolizumab) Favorable Safety Profile
Brief: Galderma Publishes New Data On Nemluvio's Safety Profile
Swiss stocks - Factors to watch on June 18
Brief: Galderma Establishes New U.S. Headquarters In Miami
Kepler starts Galderma with 'buy' on high impact product launches
Europe Research Roundup: Aegon, AXA, Sonova Holding
Brief: Galderma Says Long-Term Data On Nemluvio (Nemolizumab) Demonstrate Its Favorable Safety Profile
Swiss stocks - Factors to watch on June 6
Brief: EQT Completes Sale Of Shares In Galderma
Brief: Block Trade: Galderma ABB Priced At CHF 97.75 Per Share - Bookrunner
Brief: Galderma Says It Buys Back Shares Worth CHF 233 Million
Swiss stocks - Factors to watch on May 28
Brief: Bookrunner Says Galderma Secondary ABB's Books Closed
Brief: Galderma Secondary ABB Books Covered, Further Guidance To Follow, Says Bookrunner
Brief: Galderma ABO Orders Below CHF 97.75 Per Share Risk Missing, Says Bookrunner
Brief: Galderma Group Intends To Buy Back 2.4 Million Shares In Context Of Accelerated Bookbuild Offering By EQT, ADIA And Auba
Brief: Bookrunner Says Galderma Secondary ABB Base Deal Size C. 16.7M Shares
Europe Research Roundup: IMCD NV, Rheinmetall AG, Yara